297B Yeo, Charles - Thomas Jefferson University - Thomas Jefferson University
Charles J. Yeo, MD, FACS

Charles J. Yeo, MD, FACS

Contact Dr. Yeo

1015 Walnut Street
Curtis Building, Suite 620
Philadelphia, PA 19107

(215) 955-8643
(215) 923-6609 fax

Most Recent Peer-reviewed Publications

  1. Non-neoplastic Epithelial Cysts of the Pancreas: A Rare, Benign Entity
  2. Complex cystic lesions in the liver causing abdominal pain
  3. HuR posttranscriptionally regulates WEE1: Implications for the DNA damage response in pancreatic cancer cells
  4. Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase
  5. Does Resident Experience Affect Outcomes in Complex Abdominal Surgery? Pancreaticoduodenectomy as an Example
  6. Roscoe Reid Graham (1890 to 1948): a Canadian pioneer in general surgery.
  7. Grit: A marker of residents at risk for attrition?
  8. Intraoperative Pancreatoscopy: A Valuable Tool for Pancreatic Surgeons?
  9. Safety of perioperative aspirin therapy in pancreatic operations
  10. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery
  11. The HYSLAR trial: A prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated ringers in patients undergoing pancreaticoduodenectomy
  12. Emergent pancreaticoduodenectomy: A dual institution experience and review of the literature
  13. Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)
  14. Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma
  15. Dr. Seishu Hanaoka (1760-1835): surgeon, pharmacist, and anesthesiologist.
  16. Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
  17. Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer
  18. Mary H. Gibbon: teamwork of the heart.
  19. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: A dual-institutional follow-up with the RTOG 9704 trial
  20. Francis F. Maury, M.D. (1840 to 1879): an often forgotten pioneer in early American surgery.
0